“…The evolution of devices in serious cardiac rhythm pathology management has led progressively to the development of devices for the treatment of bradycardia, ventricular arrhythmia, and heart failure and for the prevention of sudden cardiac arrest leading to delivery of pacemakers, implantable cardioverter defibrillators (ICD)s and cardiac resynchronization therapy (CRT) plus ICD (CRT-D) and to the recent subcutaneous implantable cardioverter-defibrillator (S-ICD) [23][24][25][26][27] and subcutaneous single-finger cardioverter-defibrillator (ICD) system [28]. Infectious complications leading also to endocarditis [1,8,[29][30][31][32][33][34][35][36][37] and non-infectious complications [9,21,23,[38][39][40][41] often necessitating removal [1,2,8,[41][42][43][44][45][46][47] affect patients' wellbeing which also leads to psychological difficulty increase [48][49][50][51][52][53][54] in the emerging scenario of concomitant problems and diseases and in patients that also need device revision and upgrade. In addition, the improved patients' survival, the progressively younger implanted population and the increase in device and procedur...…”